Also listed on Irx Therapeutics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Dec 11, 2028 · High confidence
20-year base term ends Nov 26, 2028
Held by Brooklyn Immunotherapeutics LLC
Filed Nov 26, 2008 as application 12/323,595 · Granted Aug 9, 2011
Base term plus 15 days of patent term adjustment (USPTO delay)
Today
2008
2028
Clock starts
Nov 26, 2008
Nov 26, 2008
Term ends
Dec 11, 2028
Dec 11, 2028
Granted
Aug 9, 2011
Aug 9, 2011
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
15
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 15 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 26, 2008, when this application, 12/323,595, was filed | Nov 26, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +15 days, USPTO patent term adjustment record | Dec 11, 2028 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 11, 2028 | High confidence |
This family
| US 7,993,660 | this patent Dec 2028 | Dec 2028 |
| US 8,591,956 | Lapsed on the fee record Nov 2025 | Nov 2025 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 21, 2009 Reel 22292, frame 763 | Hadden, John W.; Whiteside, Theresa L.; Czystowska, Malgorzata; Egan, James E.; Signorelli, Kathy L.; Brandwein, Harvey | Irx Therapeutics, Inc. | Assignment of Assignor's Interest |
| Aug 19, 2013 Reel 31035, frame 212 | University of South Florida; Irx Therapeutics, Inc. | Kohn & Associates PLLC | Lien |
| Dec 13, 2013 Reel 31782, frame 396 | Kohn & Associates PLLC; Kohn, Kenneth I. | University of South Florida; Irx Therapeutics, Inc. | Release of Security Interest |
| Dec 13, 2013 reel/frame not recorded | Kohn & Associates PLLC; Kohn, Kenneth I. | University of South Florida | Release of Security Interest |
| Dec 13, 2013 reel/frame not recorded | Kohn & Associates PLLC; Kohn, Kenneth I. | Irx Therapeutics, Inc. | Release of Security Interest |
| Feb 25, 2019 Reel 48424, frame 96 | Irx Therapeutics, Inc. | Brooklyn Immunotherapeutics LLC | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Dec 2028
Term ends Dec 11, 2028. No further fees fall due before then
Note
The 15 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
13
later US patents cite this one
That is above the median of utility patents granted in 2011 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.